I’ll say 80/20 and maybe blushing a little though with such high level people in critical places of control I see the company ahead of the curve and zoning steadily in on ultimate success.
From Paul Rennie’s address at the AGM to a chat here and there with various interested parties I came away with very high confidence the drug will pass Phase 3 trials.
One should not hang on words but I have and I did hang on a few as totally sure the speakers I heard and spoke with have that sort of credibility to be taken seriously.
In fact the only reason I have 20% doubt is because I do not yet know the design of the trial? With the Good Doctor advising and assisting liaison with the FDA I am feeling very comfortable at this point to apply the above chance of success.
Plenty of time to pass as well before the ultimate presentation to the ASX of such a critical announcement, pretty relaxed on any risks with PAR atm.
At end this is my opinion only and DYOR is critical regards managing risk.
- Forums
- ASX - By Stock
- PAR
- Current SP appreciation
Current SP appreciation, page-254
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
20.0¢ |
Change
0.005(2.56%) |
Mkt cap ! $70.04M |
Open | High | Low | Value | Volume |
19.5¢ | 21.0¢ | 19.5¢ | $80.51K | 398.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 112938 | 20.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
21.0¢ | 4396 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 112938 | 0.200 |
8 | 185493 | 0.195 |
18 | 390135 | 0.190 |
5 | 96313 | 0.185 |
10 | 178295 | 0.180 |
Price($) | Vol. | No. |
---|---|---|
0.210 | 4396 | 1 |
0.215 | 19607 | 1 |
0.220 | 50066 | 5 |
0.225 | 68604 | 2 |
0.230 | 15000 | 3 |
Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |